| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 79 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 79 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 79 |
| 3 | DOXORUBICIN | 77 |
| 4 | CYTARABINE | 55 |
| 5 | CARBOPLATIN | 49 |
| 6 | METHOTREXATE SODIUM | 49 |
| 7 | PREDNISOLONE | 48 |
| 8 | PREDNISOLONE ORAL | 48 |
| 9 | PREDNISOLONE ORAL SOLUTION | 48 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EQUINE THYMOCYTE IMMUNE GLOBULIN | 13 | 0.0126 |
| 1 | PURIXAN | 9 | 0.0116 |
| 2 | MITOTANE | 17 | 0.0093 |
| 3 | ALITRETINOIN | 1 | 0.0084 |
| 4 | THIOGUANINE | 16 | 0.0075 |
| 5 | TRIFAROTENE | 1 | 0.0055 |
| 6 | IDARUBICIN HYDROCHLORIDE | 6 | 0.0052 |
| 7 | DIFELIKEFALIN | 2 | 0.0048 |
| 8 | DACTINOMYCIN | 10 | 0.0045 |
| 9 | PALTUSOTINE | 1 | 0.0042 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 10 | 0.0045 |
| 1 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 2 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 5 | 0.0022 |
| 3 | Thyroid Hormone Receptor beta Agonist [EPC] | 2 | 0.0009 |
| 4 | CTLA-4-directed Blocking Antibody [EPC] | 31 | 0.0006 |
| 5 | Topoisomerase Inhibitor [EPC] | 49 | 0.0006 |
| 6 | Melatonin Receptor Agonist [EPC] | 7 | 0.0005 |
| 7 | Alkylating Drug [EPC] | 95 | 0.0004 |
| 8 | Orexin Receptor Antagonist [EPC] | 7 | 0.0004 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 33 | 0.0003 |